EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Cardiovascular Safety of Testosterone-Replacement Therapy

A Michael Lincoff, Shalender Bhasin, Panagiotis Flevaris, Lisa M Mitchell, Shehzad Basaria, William E Boden, Glenn R Cunningham, Christopher B Granger, Mohit Khera, Ian M Thompson, Qiuqing Wang, Kathy Wolski und 14 weitere

New England Journal of Medicine · 13.07.2023 · 389 (2) · 107-117

DOI: 10.1056/nejmoa2215025 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift New England Journal of Medicine, erschienen am 13.07.2023. Verfasst von A Michael Lincoff und 25 weiteren Autor:innen. Beteiligte Einrichtung: From the Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland (A.M.L., L.M.…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Hypogonadism, Testosterone, Hormone Replacement Therapy. Die Arbeit wurde bisher 483-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesHypogonadismTestosteroneHormone Replacement TherapyAgedHumansMaleMiddle AgedDiabetes Mellitus, Type 2Double-Blind MethodMyocardial InfarctionStrokeAged, 80 and overGelsTransdermal Patch

Substanzen

TestosteroneGels

Autor:innen und Institutionen

  • From the Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland (A.M.L., L.M.M., Q.W., K.W., D.D., V.K., S.E.N.); the Research Program in Men's Hea…

ORCID-Profile: Steven E Nissen

Förderung

  • AbbVie

Zitieren

APA

Lincoff, A. M., Bhasin, S., Flevaris, P., Mitchell, L. M., Basaria, S., Boden, W. E., Cunningham, G. R., Granger, C. B., Khera, M., Thompson, I. M., Wang, Q., Wolski, K., Davey, D., Kalahasti, V., Khan, N., Miller, M. G., Snabes, M. C., Chan, A., Dubcenco, E., …, & TRAVERSE Study Investigators (2023). Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicine, 389(2), 107-117. https://doi.org/10.1056/nejmoa2215025

Vancouver

Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, et al. Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicine. 2023;389(2):107-117. doi:10.1056/nejmoa2215025

BibTeX
@article{Lincoff2023,
  author = {Lincoff, A Michael and Bhasin, Shalender and Flevaris, Panagiotis and Mitchell, Lisa M and Basaria, Shehzad and Boden, William E and Cunningham, Glenn R and Granger, Christopher B and Khera, Mohit and Thompson, Ian M and Wang, Qiuqing and Wolski, Kathy and Davey, Deborah and Kalahasti, Vidyasagar and Khan, Nader and Miller, Michael G and Snabes, Michael C and Chan, Anna and Dubcenco, Elena and Li, Xue and Yi, Tingting and Huang, Bidan and Pencina, Karol M and Travison, Thomas G and Nissen, Steven E and TRAVERSE Study Investigators, TRAVERSE Study Investigators},
  title = {Cardiovascular Safety of Testosterone-Replacement Therapy},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {2},
  pages = {107--117},
  doi = {10.1056/nejmoa2215025}
}
Kostenlos starten →